Sartorius to Add French Biopharma Supplier Stedim to Biotech Division | GenomeWeb
NEW YORK (GenomeWeb News) — Lab products maker Sartorius will buy a “substantial stake” in French company Stedim, which it plans to combine with its biotechnology division, Sartorius said last week.
 
Stedim makes disposable bag and door systems for biopharmaceutical use, and it owns a freeze-thaw technology, Sartorius said.
 
The new division would be called Sartorius Stedim Biotech, and would include seven board members from Sartorius and three from Stedim.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.